172 related articles for article (PubMed ID: 20432232)
21. CD248+ stromal cells are associated with progressive chronic kidney disease.
Smith SW; Eardley KS; Croft AP; Nwosu J; Howie AJ; Cockwell P; Isacke CM; Buckley CD; Savage CO
Kidney Int; 2011 Jul; 80(2):199-207. PubMed ID: 21490589
[TBL] [Abstract][Full Text] [Related]
22. Modified TLR-mediated downregulation of miR-125b-5p enhances CD248 (endosialin)-induced metastasis and drug resistance in colorectal cancer cells.
Park GB; Jeong JY; Kim D
Mol Carcinog; 2020 Feb; 59(2):154-167. PubMed ID: 31746054
[TBL] [Abstract][Full Text] [Related]
23. Endosialin Promotes Atherosclerosis Through Phenotypic Remodeling of Vascular Smooth Muscle Cells.
Hasanov Z; Ruckdeschel T; König C; Mogler C; Kapel SS; Korn C; Spegg C; Eichwald V; Wieland M; Appak S; Augustin HG
Arterioscler Thromb Vasc Biol; 2017 Mar; 37(3):495-505. PubMed ID: 28126825
[TBL] [Abstract][Full Text] [Related]
24. Metabolic consequences for mice lacking Endosialin: LC-MS/MS-based metabolic phenotyping of serum from C56Bl/6J Control and CD248 knock-out mice.
Armitage EG; Barnes A; Patrick K; Bechar J; Harrison MJ; Lavery GG; Rainger GE; Buckley CD; Loftus NJ; Wilson ID; Naylor AJ
Metabolomics; 2021 Jan; 17(2):14. PubMed ID: 33462674
[TBL] [Abstract][Full Text] [Related]
25. Pericytes promote selective vessel regression to regulate vascular patterning.
Simonavicius N; Ashenden M; van Weverwijk A; Lax S; Huso DL; Buckley CD; Huijbers IJ; Yarwood H; Isacke CM
Blood; 2012 Aug; 120(7):1516-27. PubMed ID: 22740442
[TBL] [Abstract][Full Text] [Related]
26. CD248 and its cytoplasmic domain: a therapeutic target for arthritis.
Maia M; de Vriese A; Janssens T; Moons M; van Landuyt K; Tavernier J; Lories RJ; Conway EM
Arthritis Rheum; 2010 Dec; 62(12):3595-606. PubMed ID: 20722022
[TBL] [Abstract][Full Text] [Related]
27. Targeting fibroblast CD248 attenuates CCL17-expressing macrophages and tissue fibrosis.
Pai CH; Lin SR; Liu CH; Pan SY; Hsu H; Chen YT; Yen CT; Yu IS; Wu HL; Lin SL; Lin SW
Sci Rep; 2020 Oct; 10(1):16772. PubMed ID: 33033277
[TBL] [Abstract][Full Text] [Related]
28. TGFβ-mediated suppression of CD248 in non-cancer cells via canonical Smad-dependent signaling pathways is uncoupled in cancer cells.
Suresh Babu S; Valdez Y; Xu A; O'Byrne AM; Calvo F; Lei V; Conway EM
BMC Cancer; 2014 Feb; 14():113. PubMed ID: 24555435
[TBL] [Abstract][Full Text] [Related]
29. Facultative role of germinal centers and T cells in the somatic diversification of IgVH genes.
Miller C; Stedra J; Kelsoe G; Cerny J
J Exp Med; 1995 Apr; 181(4):1319-31. PubMed ID: 7535332
[TBL] [Abstract][Full Text] [Related]
30. Transcriptional profiling of stroma from inflamed and resting lymph nodes defines immunological hallmarks.
Malhotra D; Fletcher AL; Astarita J; Lukacs-Kornek V; Tayalia P; Gonzalez SF; Elpek KG; Chang SK; Knoblich K; Hemler ME; Brenner MB; Carroll MC; Mooney DJ; Turley SJ;
Nat Immunol; 2012 Apr; 13(5):499-510. PubMed ID: 22466668
[TBL] [Abstract][Full Text] [Related]
31. Endosialin (CD248) is a marker of tumor-associated pericytes in high-grade glioma.
Simonavicius N; Robertson D; Bax DA; Jones C; Huijbers IJ; Isacke CM
Mod Pathol; 2008 Mar; 21(3):308-15. PubMed ID: 18192970
[TBL] [Abstract][Full Text] [Related]
32. Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: a new potential target for antifibrotic therapy.
Di Benedetto P; Liakouli V; Ruscitti P; Berardicurti O; Carubbi F; Panzera N; Di Bartolomeo S; Guggino G; Ciccia F; Triolo G; Cipriani P; Giacomelli R
Arthritis Res Ther; 2018 Oct; 20(1):223. PubMed ID: 30285896
[TBL] [Abstract][Full Text] [Related]
33. Novel monoclonal antibodies specific for CTLD-SSC and sialomucin domains of endosialin, a mural cell marker of tumor vasculature.
Kontseková S; Ohradanova Repic A; Polčicová K; Tuomaala P; Pastorek J; Pastoreková S; Parkkila S; Baráthová M
Int J Oncol; 2012 Oct; 41(4):1365-72. PubMed ID: 22824847
[TBL] [Abstract][Full Text] [Related]
34. Specific loss of adipocyte CD248 improves metabolic health via reduced white adipose tissue hypoxia, fibrosis and inflammation.
Petrus P; Fernandez TL; Kwon MM; Huang JL; Lei V; Safikhan NS; Karunakaran S; O'Shannessy DJ; Zheng X; Catrina SB; Albone E; Laine J; Virtanen K; Clee SM; Kieffer TJ; Noll C; Carpentier AC; Johnson JD; Rydén M; Conway EM
EBioMedicine; 2019 Jun; 44():489-501. PubMed ID: 31221584
[TBL] [Abstract][Full Text] [Related]
35. IL-21 receptor is critical for the development of memory B cell responses.
Rankin AL; MacLeod H; Keegan S; Andreyeva T; Lowe L; Bloom L; Collins M; Nickerson-Nutter C; Young D; Guay H
J Immunol; 2011 Jan; 186(2):667-74. PubMed ID: 21169545
[TBL] [Abstract][Full Text] [Related]
36. CXCL12 derived from CD248-expressing cancer-associated fibroblasts mediates M2-polarized macrophages to promote nonsmall cell lung cancer progression.
Wu J; Liu X; Wu J; Lou C; Zhang Q; Chen H; Yang Z; Long S; Wang Y; Shang Z; Hu Z; Zhang R; Zhang J; Zeng Z
Biochim Biophys Acta Mol Basis Dis; 2022 Nov; 1868(11):166521. PubMed ID: 35985448
[TBL] [Abstract][Full Text] [Related]
37. A periarteriolar lymphoid sheath-associated B cell focus response is not observed during the development of the anti-arsonate germinal center reaction.
Vora KA; Tumas-Brundage KM; Manser T
J Immunol; 1998 Jan; 160(2):728-33. PubMed ID: 9551908
[TBL] [Abstract][Full Text] [Related]
38. Endosialin in Cancer: Expression Patterns, Mechanistic Insights, and Therapeutic Approaches.
Lu S; Gan L; Lu T; Zhang K; Zhang J; Wu X; Han D; Xu C; Liu S; Yang F; Qin W; Wen W
Theranostics; 2024; 14(1):379-391. PubMed ID: 38164138
[TBL] [Abstract][Full Text] [Related]
39. Disrupted lymph node and splenic stroma in mice with induced inflammatory melanomas is associated with impaired recruitment of T and dendritic cells.
Soudja SM; Henri S; Mello M; Chasson L; Mas A; Wehbe M; Auphan-Anezin N; Leserman L; Van den Eynde B; Schmitt-Verhulst AM
PLoS One; 2011; 6(7):e22639. PubMed ID: 21811640
[TBL] [Abstract][Full Text] [Related]
40. CD248 and integrin alpha-8 are candidate markers for differentiating lung fibroblast subtypes.
Matsushima S; Aoshima Y; Akamatsu T; Enomoto Y; Meguro S; Kosugi I; Kawasaki H; Fujisawa T; Enomoto N; Nakamura Y; Inui N; Funai K; Suda T; Iwashita T
BMC Pulm Med; 2020 Jan; 20(1):21. PubMed ID: 31964365
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
